000139442 001__ 139442
000139442 005__ 20210129212606.0
000139442 0247_ $$2DOI$$a10.1097/MNM.0000000000000036
000139442 0247_ $$2wos$$aWOS:000331291000004
000139442 0247_ $$2altmetric$$aaltmetric:1926048
000139442 0247_ $$2pmid$$apmid:24240195
000139442 037__ $$aFZJ-2013-05431
000139442 082__ $$a610
000139442 1001_ $$0P:(DE-Juel1)142359$$aZhang, Ke$$b0$$eCorresponding author$$ufzj
000139442 245__ $$aRelationship of Regional Cerebral Blood Flow and Kinetic Behaviour of O-(2-18F- Fluoroethyl)-L-Tyrosine Uptake in Cerebral Gliomas.
000139442 260__ $$aLondon$$bLippincott Williams & Wilkins$$c2014
000139442 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1397550449_17877
000139442 3367_ $$2DataCite$$aOutput Types/Journal article
000139442 3367_ $$00$$2EndNote$$aJournal Article
000139442 3367_ $$2BibTeX$$aARTICLE
000139442 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000139442 3367_ $$2DRIVER$$aarticle
000139442 520__ $$aObjectives: O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) is an established tracer for brain tumour imaging. 18F-FET kinetics in gliomas appear to have potential for tumour grading, but the mechanisms remain unclear. The aim of this study was to explore the relationship between regional cerebral blood flow (rCBF) as measured by arterial spin labelling MRI and the kinetic behaviour of 18F-FET PET in cerebral gliomas.Materials and methods: Twenty patients with cerebral gliomas were investigated using arterial spin labelling MRI and dynamic 18F-FET PET. Time–activity curves (TACs) of 18F-FET uptake were analysed in 33 different tumour regions. The slopes of TAC during the early (0–5 min; slopeup) and late phases of tracer uptake (17–50 min; slopedown) were fitted using linear regression lines. In addition, TACs of each lesion were assigned to different curve patterns. Furthermore, we calculated tumour-to-brain ratios of 18F-FET uptake. The relationship between 18F-FET parameters and rCBF was determined.Results: 18F-FET uptake in the early phase (slopeup) showed a significant correlation with rCBF (r=0.4; P=0.02). In contrast, both slopedown and TAC patterns showed no significant correlation with rCBF. Furthermore, a significant correlation was found between rCBF and tumour-to-brain ratio (r=0.53; P=0.002).Conclusion: There is a relationship between rCBF and 18F-FET uptake in cerebral gliomas in the initial uptake phase, but the kinetic behaviour of 18F-FET uptake in the late phase is not significantly influenced by rCBF. Thus, the differential kinetic pattern of 18F-FET uptake in high-grade and low-grade gliomas appears to be determined by factors other than rCBF
000139442 536__ $$0G:(DE-HGF)POF2-333$$a333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)$$cPOF2-333$$fPOF II$$x0
000139442 536__ $$0G:(DE-HGF)POF2-89572$$a89572 - (Dys-)function and Plasticity (POF2-89572)$$cPOF2-89572$$fPOF II T$$x1
000139442 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b1$$ufzj
000139442 7001_ $$0P:(DE-Juel1)131781$$aNeuner, Irene$$b2$$ufzj
000139442 7001_ $$0P:(DE-Juel1)131627$$aStoffels, Gabriele$$b3$$ufzj
000139442 7001_ $$0P:(DE-Juel1)141877$$aFilss, Christian$$b4$$ufzj
000139442 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b5$$ufzj
000139442 7001_ $$0P:(DE-Juel1)131797$$aTellmann, Lutz$$b6$$ufzj
000139442 7001_ $$0P:(DE-Juel1)131788$$aRota Kops, Elena$$b7$$ufzj
000139442 7001_ $$0P:(DE-Juel1)131816$$aCoenen, Heinrich Hubert$$b8$$ufzj
000139442 7001_ $$0P:(DE-Juel1)131768$$aHerzog, Hans$$b9$$ufzj
000139442 7001_ $$0P:(DE-Juel1)131794$$aShah, N. J.$$b10$$ufzj
000139442 773__ $$0PERI:(DE-600)2028880-3$$a10.1097/MNM.0000000000000036$$n3$$p245–251$$tNuclear medicine communications$$v35$$x1473-5628$$y2014
000139442 909CO $$ooai:juser.fz-juelich.de:139442$$pVDB
000139442 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)142359$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000139442 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich GmbH$$b1$$kFZJ
000139442 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131781$$aForschungszentrum Jülich GmbH$$b2$$kFZJ
000139442 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131627$$aForschungszentrum Jülich GmbH$$b3$$kFZJ
000139442 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)141877$$aForschungszentrum Jülich GmbH$$b4$$kFZJ
000139442 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich GmbH$$b5$$kFZJ
000139442 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131797$$aForschungszentrum Jülich GmbH$$b6$$kFZJ
000139442 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131788$$aForschungszentrum Jülich GmbH$$b7$$kFZJ
000139442 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131816$$aForschungszentrum Jülich GmbH$$b8$$kFZJ
000139442 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131768$$aForschungszentrum Jülich GmbH$$b9$$kFZJ
000139442 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131794$$aForschungszentrum Jülich GmbH$$b10$$kFZJ
000139442 9141_ $$y2014
000139442 915__ $$0StatID:(DE-HGF)0010$$2StatID$$aJCR/ISI refereed
000139442 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000139442 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000139442 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000139442 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000139442 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000139442 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000139442 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000139442 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000139442 9132_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000139442 9131_ $$0G:(DE-HGF)POF2-333$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lFunktion und Dysfunktion des Nervensystems$$vPathophysiological Mechanisms of Neurological and Psychiatric Diseases$$x0
000139442 9131_ $$0G:(DE-HGF)POF2-89572$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$v(Dys-)function and Plasticity$$x1
000139442 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000139442 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000139442 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x2
000139442 980__ $$ajournal
000139442 980__ $$aVDB
000139442 980__ $$aI:(DE-Juel1)INM-3-20090406
000139442 980__ $$aI:(DE-Juel1)INM-4-20090406
000139442 980__ $$aI:(DE-Juel1)INM-5-20090406
000139442 980__ $$aUNRESTRICTED
000139442 981__ $$aI:(DE-Juel1)INM-4-20090406
000139442 981__ $$aI:(DE-Juel1)INM-5-20090406